A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial
Background. There is a well-recognized association between substance use and psychotic disorders, sometimes described as ‘dual diagnosis’. The use of substances by people with psychosis has a negative impact in terms of symptoms, longitudinal course of illness and psychosocial adjustment. There are...
Gespeichert in:
| Veröffentlicht in: | Psychological medicine 2004-08, Vol.34 (6), p.983-990 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 990 |
|---|---|
| container_issue | 6 |
| container_start_page | 983 |
| container_title | Psychological medicine |
| container_volume | 34 |
| creator | JAMES, W. PRESTON, N. J. KOH, G. SPENCER, C. KISELY, S. R. CASTLE, D. J. |
| description | Background. There is a well-recognized association between substance use and psychotic disorders, sometimes described as ‘dual diagnosis’. The use of substances by people with psychosis has a negative impact in terms of symptoms, longitudinal course of illness and psychosocial adjustment. There are few validated treatments for such individuals, and those that do exist are usually impracticable in routine clinical settings. The present study employs a randomized controlled experimental design to examine the effectiveness of a manualized group-based intervention in helping patients with dual diagnosis reduce their substance use. Method. The active intervention consisted of weekly 90-min sessions over 6 weeks. The manualized intervention was tailored to participants' stage of change and motivations for drug use. The control condition was a single educational session. Results. Sixty-three subjects participated, of whom 58 (92%) completed a 3-month follow-up assessment of psychopathology, medication and substance use. Significant reductions in favour of the treatment condition were observed for psychopathology, chlorpromazine equivalent dose of antipsychotics, alcohol and illicit substance use, severity of dependence and hospitalization. Conclusions. It is possible to reduce substance use in individuals with psychotic disorders, using a targeted group-based approach. This has important implications for clinicians who wish to improve the long-term outcome of their patients. |
| doi_str_mv | 10.1017/S0033291703001648 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_57071719</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0033291703001648</cupid><sourcerecordid>810071541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-8445fbb6afe154e29401f220b0334e233cdcd8d0b80f4d829a89249ee1cbf2a23</originalsourceid><addsrcrecordid>eNp1kUGLFDEQhYMo7rj6A7xIEPTWmqST7sTbMji74oCIeg7ppHoma3dnTNKu-uvNMI0DiqdK8b4qXuUh9JSSV5TQ9vUnQuqaKdqSmhDacHkPrShvVCVVK--j1VGujvoFepTSbWFqytlDdEGFEFw0aoXyFd7FMB-wnzLE7zBlHyZ8t_d2j01KPuWEDyb7IiR85_Meu9kM2Hmzm0KRcQQ3W8B5Dz5iF-cdnhO8wQZHM7kw-l_gsA1TjmEYyjNHb4bH6EFvhgRPlnqJvmzefl7fVNsP1-_WV9vKCiFzJTkXfdc1pgcqODDFCe0ZI105q7R1bZ110pFOkp47yZSRinEFQG3XM8PqS_TytPcQw7cZUtajTxaGwUwQ5qRFS1raUlXA53-Bt2GOU_GmGeGCUsWPED1BNoaUIvT6EP1o4k9NiT7mof_Jo8w8WxbP3QjuPLEEUIAXC2CSNUNffs36dOYaIjklvHDViSuJwI8_uolfddPWrdDN9Ud9s96uN_T9Vm8KXy9mzdhF73ZwPun_dn8DZ7Oxrg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204511949</pqid></control><display><type>article</type><title>A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial</title><source>MEDLINE</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Cambridge University Press Journals Complete</source><creator>JAMES, W. ; PRESTON, N. J. ; KOH, G. ; SPENCER, C. ; KISELY, S. R. ; CASTLE, D. J.</creator><creatorcontrib>JAMES, W. ; PRESTON, N. J. ; KOH, G. ; SPENCER, C. ; KISELY, S. R. ; CASTLE, D. J.</creatorcontrib><description>Background. There is a well-recognized association between substance use and psychotic disorders, sometimes described as ‘dual diagnosis’. The use of substances by people with psychosis has a negative impact in terms of symptoms, longitudinal course of illness and psychosocial adjustment. There are few validated treatments for such individuals, and those that do exist are usually impracticable in routine clinical settings. The present study employs a randomized controlled experimental design to examine the effectiveness of a manualized group-based intervention in helping patients with dual diagnosis reduce their substance use. Method. The active intervention consisted of weekly 90-min sessions over 6 weeks. The manualized intervention was tailored to participants' stage of change and motivations for drug use. The control condition was a single educational session. Results. Sixty-three subjects participated, of whom 58 (92%) completed a 3-month follow-up assessment of psychopathology, medication and substance use. Significant reductions in favour of the treatment condition were observed for psychopathology, chlorpromazine equivalent dose of antipsychotics, alcohol and illicit substance use, severity of dependence and hospitalization. Conclusions. It is possible to reduce substance use in individuals with psychotic disorders, using a targeted group-based approach. This has important implications for clinicians who wish to improve the long-term outcome of their patients.</description><identifier>ISSN: 0033-2917</identifier><identifier>EISSN: 1469-8978</identifier><identifier>DOI: 10.1017/S0033291703001648</identifier><identifier>PMID: 15554569</identifier><identifier>CODEN: PSMDCO</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Adult ; Australia ; Biological and medical sciences ; Clinical trials ; Diagnosis, Dual (Psychiatry) ; Drug use ; Female ; Group psychotherapy ; Group therapy ; Humans ; Male ; Medical sciences ; Mental disorders ; Patients ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Psychotherapies. Psychological and clinical counseling ; Psychotherapy, Group ; Psychotic Disorders - complications ; Psychotic Disorders - psychology ; Psychotic Disorders - therapy ; Randomized controlled trials ; Reduction ; Substance abuse ; Substance abuse treatment ; Substance-Related Disorders - complications ; Substance-Related Disorders - psychology ; Substance-Related Disorders - therapy ; Treatment Outcome ; Treatments</subject><ispartof>Psychological medicine, 2004-08, Vol.34 (6), p.983-990</ispartof><rights>2004 Cambridge University Press</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Cambridge University Press, Publishing Division Aug 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558t-8445fbb6afe154e29401f220b0334e233cdcd8d0b80f4d829a89249ee1cbf2a23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0033291703001648/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,776,780,12826,27903,27904,30978,30979,55607</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16084104$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15554569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JAMES, W.</creatorcontrib><creatorcontrib>PRESTON, N. J.</creatorcontrib><creatorcontrib>KOH, G.</creatorcontrib><creatorcontrib>SPENCER, C.</creatorcontrib><creatorcontrib>KISELY, S. R.</creatorcontrib><creatorcontrib>CASTLE, D. J.</creatorcontrib><title>A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial</title><title>Psychological medicine</title><addtitle>Psychol. Med</addtitle><description>Background. There is a well-recognized association between substance use and psychotic disorders, sometimes described as ‘dual diagnosis’. The use of substances by people with psychosis has a negative impact in terms of symptoms, longitudinal course of illness and psychosocial adjustment. There are few validated treatments for such individuals, and those that do exist are usually impracticable in routine clinical settings. The present study employs a randomized controlled experimental design to examine the effectiveness of a manualized group-based intervention in helping patients with dual diagnosis reduce their substance use. Method. The active intervention consisted of weekly 90-min sessions over 6 weeks. The manualized intervention was tailored to participants' stage of change and motivations for drug use. The control condition was a single educational session. Results. Sixty-three subjects participated, of whom 58 (92%) completed a 3-month follow-up assessment of psychopathology, medication and substance use. Significant reductions in favour of the treatment condition were observed for psychopathology, chlorpromazine equivalent dose of antipsychotics, alcohol and illicit substance use, severity of dependence and hospitalization. Conclusions. It is possible to reduce substance use in individuals with psychotic disorders, using a targeted group-based approach. This has important implications for clinicians who wish to improve the long-term outcome of their patients.</description><subject>Adult</subject><subject>Australia</subject><subject>Biological and medical sciences</subject><subject>Clinical trials</subject><subject>Diagnosis, Dual (Psychiatry)</subject><subject>Drug use</subject><subject>Female</subject><subject>Group psychotherapy</subject><subject>Group therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mental disorders</subject><subject>Patients</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Psychotherapies. Psychological and clinical counseling</subject><subject>Psychotherapy, Group</subject><subject>Psychotic Disorders - complications</subject><subject>Psychotic Disorders - psychology</subject><subject>Psychotic Disorders - therapy</subject><subject>Randomized controlled trials</subject><subject>Reduction</subject><subject>Substance abuse</subject><subject>Substance abuse treatment</subject><subject>Substance-Related Disorders - complications</subject><subject>Substance-Related Disorders - psychology</subject><subject>Substance-Related Disorders - therapy</subject><subject>Treatment Outcome</subject><subject>Treatments</subject><issn>0033-2917</issn><issn>1469-8978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kUGLFDEQhYMo7rj6A7xIEPTWmqST7sTbMji74oCIeg7ppHoma3dnTNKu-uvNMI0DiqdK8b4qXuUh9JSSV5TQ9vUnQuqaKdqSmhDacHkPrShvVCVVK--j1VGujvoFepTSbWFqytlDdEGFEFw0aoXyFd7FMB-wnzLE7zBlHyZ8t_d2j01KPuWEDyb7IiR85_Meu9kM2Hmzm0KRcQQ3W8B5Dz5iF-cdnhO8wQZHM7kw-l_gsA1TjmEYyjNHb4bH6EFvhgRPlnqJvmzefl7fVNsP1-_WV9vKCiFzJTkXfdc1pgcqODDFCe0ZI105q7R1bZ110pFOkp47yZSRinEFQG3XM8PqS_TytPcQw7cZUtajTxaGwUwQ5qRFS1raUlXA53-Bt2GOU_GmGeGCUsWPED1BNoaUIvT6EP1o4k9NiT7mof_Jo8w8WxbP3QjuPLEEUIAXC2CSNUNffs36dOYaIjklvHDViSuJwI8_uolfddPWrdDN9Ud9s96uN_T9Vm8KXy9mzdhF73ZwPun_dn8DZ7Oxrg</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>JAMES, W.</creator><creator>PRESTON, N. J.</creator><creator>KOH, G.</creator><creator>SPENCER, C.</creator><creator>KISELY, S. R.</creator><creator>CASTLE, D. J.</creator><general>Cambridge University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20040801</creationdate><title>A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial</title><author>JAMES, W. ; PRESTON, N. J. ; KOH, G. ; SPENCER, C. ; KISELY, S. R. ; CASTLE, D. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-8445fbb6afe154e29401f220b0334e233cdcd8d0b80f4d829a89249ee1cbf2a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Australia</topic><topic>Biological and medical sciences</topic><topic>Clinical trials</topic><topic>Diagnosis, Dual (Psychiatry)</topic><topic>Drug use</topic><topic>Female</topic><topic>Group psychotherapy</topic><topic>Group therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mental disorders</topic><topic>Patients</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Psychotherapies. Psychological and clinical counseling</topic><topic>Psychotherapy, Group</topic><topic>Psychotic Disorders - complications</topic><topic>Psychotic Disorders - psychology</topic><topic>Psychotic Disorders - therapy</topic><topic>Randomized controlled trials</topic><topic>Reduction</topic><topic>Substance abuse</topic><topic>Substance abuse treatment</topic><topic>Substance-Related Disorders - complications</topic><topic>Substance-Related Disorders - psychology</topic><topic>Substance-Related Disorders - therapy</topic><topic>Treatment Outcome</topic><topic>Treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JAMES, W.</creatorcontrib><creatorcontrib>PRESTON, N. J.</creatorcontrib><creatorcontrib>KOH, G.</creatorcontrib><creatorcontrib>SPENCER, C.</creatorcontrib><creatorcontrib>KISELY, S. R.</creatorcontrib><creatorcontrib>CASTLE, D. J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Psychological medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JAMES, W.</au><au>PRESTON, N. J.</au><au>KOH, G.</au><au>SPENCER, C.</au><au>KISELY, S. R.</au><au>CASTLE, D. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial</atitle><jtitle>Psychological medicine</jtitle><addtitle>Psychol. Med</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>34</volume><issue>6</issue><spage>983</spage><epage>990</epage><pages>983-990</pages><issn>0033-2917</issn><eissn>1469-8978</eissn><coden>PSMDCO</coden><abstract>Background. There is a well-recognized association between substance use and psychotic disorders, sometimes described as ‘dual diagnosis’. The use of substances by people with psychosis has a negative impact in terms of symptoms, longitudinal course of illness and psychosocial adjustment. There are few validated treatments for such individuals, and those that do exist are usually impracticable in routine clinical settings. The present study employs a randomized controlled experimental design to examine the effectiveness of a manualized group-based intervention in helping patients with dual diagnosis reduce their substance use. Method. The active intervention consisted of weekly 90-min sessions over 6 weeks. The manualized intervention was tailored to participants' stage of change and motivations for drug use. The control condition was a single educational session. Results. Sixty-three subjects participated, of whom 58 (92%) completed a 3-month follow-up assessment of psychopathology, medication and substance use. Significant reductions in favour of the treatment condition were observed for psychopathology, chlorpromazine equivalent dose of antipsychotics, alcohol and illicit substance use, severity of dependence and hospitalization. Conclusions. It is possible to reduce substance use in individuals with psychotic disorders, using a targeted group-based approach. This has important implications for clinicians who wish to improve the long-term outcome of their patients.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>15554569</pmid><doi>10.1017/S0033291703001648</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0033-2917 |
| ispartof | Psychological medicine, 2004-08, Vol.34 (6), p.983-990 |
| issn | 0033-2917 1469-8978 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_57071719 |
| source | MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); Cambridge University Press Journals Complete |
| subjects | Adult Australia Biological and medical sciences Clinical trials Diagnosis, Dual (Psychiatry) Drug use Female Group psychotherapy Group therapy Humans Male Medical sciences Mental disorders Patients Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Psychotherapies. Psychological and clinical counseling Psychotherapy, Group Psychotic Disorders - complications Psychotic Disorders - psychology Psychotic Disorders - therapy Randomized controlled trials Reduction Substance abuse Substance abuse treatment Substance-Related Disorders - complications Substance-Related Disorders - psychology Substance-Related Disorders - therapy Treatment Outcome Treatments |
| title | A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T08%3A28%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20group%20intervention%20which%20assists%20patients%20with%20dual%20diagnosis%20reduce%20their%20drug%20use:%20a%20randomized%20controlled%20trial&rft.jtitle=Psychological%20medicine&rft.au=JAMES,%20W.&rft.date=2004-08-01&rft.volume=34&rft.issue=6&rft.spage=983&rft.epage=990&rft.pages=983-990&rft.issn=0033-2917&rft.eissn=1469-8978&rft.coden=PSMDCO&rft_id=info:doi/10.1017/S0033291703001648&rft_dat=%3Cproquest_cross%3E810071541%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204511949&rft_id=info:pmid/15554569&rft_cupid=10_1017_S0033291703001648&rfr_iscdi=true |